• Giuseppe Barbanti-Brodano
Part of the Infectious agents and pathogenesis book series (IAPA)


Viruses of the papovavirus group belong taxonomically to the family Papovaviridae.(1,2) The family is subdivided into two genera, Papillomavirus and Polyomavirus, whose members are widely distributed among several mammalian species. However, knowledge of immunologic aspects is limited to a few viruses of the group, the object of this chapter.


Human Papilloma Virus Progressive Multifocal Leukoencephalopathy Latent Infection Progressive Multifocal Leukoencephalopathy Human Papilloma Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Melnick, J. L., A. C. Allison, J. S. Butel, W. Eckhart, B. E. Eddy, S. Kit, A.J. Levine, J. A. R. Miles, J. S. Pagano, L. Sachs, and V. Vonka, Papovaviridae, Intervirology ,3:106–120 (1974).PubMedCrossRefGoogle Scholar
  2. 2.
    Melnick, J. L., Taxonomy and nomenclature of viruses, Prog. Med. Virol. 28:208–221 (1982).PubMedGoogle Scholar
  3. 3.
    Tegtmeyer, P. Genetics of SV40 and polyoma virus, in: Molecular Biology of Tumor Viruses ,Vol. 2: DNA Tumor Viruses ,J. Tooze (ed.), P. 297–337. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1980).Google Scholar
  4. 4.
    Pfister, H., Biology and biochemistry of papillomaviruses, Rev. Physiol. Biochem. Pharmacol. 99:111–181 (1984).PubMedCrossRefGoogle Scholar
  5. 5.
    Smith, K. T., and M. S. Campo, The biology of papillomaviruses and their role in oncogenesis, Anticancer Res. 5:31–48 (1985).PubMedGoogle Scholar
  6. 6.
    Kidd, J. G., J. W. Beard, and P. Rous, Serological reaction with a virus causing a rabbit papilloma which becomes cancerous. II. Tests of the blood of animals carrying various tumors, J Exp. Mod. 64:63–78 (1936).CrossRefGoogle Scholar
  7. 7.
    Seto A., K. Notake, M. Kawanishi, and Y. Ito, Development and regression of Shope papillomas induced in newborn domestic rabbits, Proc. Soc. Exp. Biol. Med. 156:64–67 (1977)PubMedGoogle Scholar
  8. 8.
    Kreider, J. W., Neoplastic progression of the Shope rabbit papilloma, Cold Spring Harbor Conf. Cell Proli. 7:283–300 (1980).Google Scholar
  9. 9.
    Hellström, I., C. A. Evans, and K. E. Hellström, Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomatosis, Int. J. Cancer 4:601 -607 (1969).PubMedCrossRefGoogle Scholar
  10. 10.
    McMichael, H., Inhibition by methylprednisolone of regression of the Shope rabbit papilloma,/. Natl. Cancer Inst. 39:55–65 (1967).PubMedGoogle Scholar
  11. 11.
    Jarrett, W. F. H., P. E. McNeil, W. T. R. Grimshaw, I. E. Selman, and W. I. M. Mclntyre, High incidence area of cattle cancer with a possible interaction between an environmental carcinogen and a papilloma virus, Nature (Lond.) 274:215–217 (1978).CrossRefGoogle Scholar
  12. 12.
    Campo, M. S., M. H. Moar, W. F. H. Jarrett, and H. M. Laird, A new papillomavirus associated with alimentary tract cancer in cattle, Nature (Lond.) 286:180–182 (1980).CrossRefGoogle Scholar
  13. 13.
    Almeida, J. D., and A. P. Goffe, Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests, Lancet 2:1205–1207 (1965).PubMedCrossRefGoogle Scholar
  14. 14.
    Almeida, J. D., J. D. Oriel, and L. M. Stannard, Characterization of the virus found in human genital warts, Microbios 3:225–232 (1969).Google Scholar
  15. 15.
    Cubie H. A., Serological studies in a student population prone to infection with human papilloma virus, J. Hyg. 70:677–690 (1972).CrossRefGoogle Scholar
  16. 16.
    Pfister, H., and H. zur Hausen, Seroepidemiological studies of human papilloma virus (HPL-1) infections, Int. J. Cancer 21:161–165 (1978).PubMedCrossRefGoogle Scholar
  17. 17.
    Matthews, R. S. and P. V. Shirodaria, Study of regressing warts by immunofluorescence, Lancet 1:689–691 (1973)PubMedCrossRefGoogle Scholar
  18. 18.
    Shirodaria, P. V., and R. S. Matthews, An immunofluorescence study of warts, Clin. Exp. Immunol. 21:329–338 (1975).PubMedGoogle Scholar
  19. 19.
    Ogilvie, M. M., Serological studies with human papova (wart) virus, J. Hyg. 68:479–483 (1970).CrossRefGoogle Scholar
  20. 20.
    Genner, J., Verruca vulgaris. II. Demonstration of a complement fixation reaction, Acta Derm. Venereol. (Stockh) 51:365–373 (1971).Google Scholar
  21. 21.
    Pyrhönen, S., and K. Penttinen, Wart virus antibodies and the prognosis of wart disease, Lancet 2:1330–1332 (1972).PubMedCrossRefGoogle Scholar
  22. 22.
    Pyrhönen, S., and E. Johansson, Regression of warts. An immunological study, Lancet 1:592–596 (1975).PubMedCrossRefGoogle Scholar
  23. 23.
    Brodersen, I., and J. Genner, Histological and immunological observations on common warts in regression, Acta Derm. Venereol. 53:461–464 (1973).PubMedGoogle Scholar
  24. 24.
    Pfíster, H., G. Gross, and M. Hagedorn, Characterization of human papillomavirus 3 in warts of a renal allograft patient, J. Invest. Dermatol. 73:349–353 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    Pass, F., and J. V. Maizel, Wart-associated antigens. II. Human immunity to viral struc tural proteins, J. Invest. Dermatol. 60:397–311 (1973).Google Scholar
  26. 26.
    Spencer, E. S., and H. K. Anderson, Clinically evident non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft patients, Br. Med. J. 111:251–254 (1970)CrossRefGoogle Scholar
  27. 27.
    Starzl, T. E., K. A. Porter, G. Andres, C. G. Halgrimson, R. Hurwitz, G. Giles, P. I. Terasaki, I. Penn, G. T. Schroter, J. Lilly, S. J. Starkie, and C. W. Putman, Long-term survival after renal transplantation in humans, Ann. Surg. 172:437–472 (1970).PubMedCrossRefGoogle Scholar
  28. 28.
    Koranda, F. C., E. M. Dehmel, G. Kahn, and I. Penn, Cutaneous complications in immunosuppressed renal homograft recipients, JAMA 229:419–424 (1974).PubMedCrossRefGoogle Scholar
  29. 29.
    Perry T. L., and L. Harman, Warts in diseases with immune defects, Cutis 13:359–362 (1974).Google Scholar
  30. 30.
    Morison, W. L., Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasms, Br. J. Dermatol. 92:625–630 (1975).PubMedCrossRefGoogle Scholar
  31. 31.
    Reid, T. M. S., N. G. Fraser, and I. R. Kernohan, Generalized warts and immune deficiency, Br. J. Dermatol. 95:559–564 (1976).PubMedCrossRefGoogle Scholar
  32. 32.
    Ward, M., A. Le Roux, W. P. Small, and W. Sircus, Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad. J. 53:753–757 (1977).CrossRefGoogle Scholar
  33. 33.
    Takigawa, M., H. Tagami, S. Watanabe, A. Ogino, S. Imamura, and S. Ofugi, Recovery processes during regression of plane warts, Arch. Dermatol. 113:1214–1218 (1977).PubMedCrossRefGoogle Scholar
  34. 34.
    Oguchi, M., J. Komura, H. Tagami, and S. Ofuji, Ultrastructural studies of spontaneously regressing plane warts. Macrophages attack verruca-epidermal cells, Arch. Dermatol. Res. 270:403–411 (1981).PubMedCrossRefGoogle Scholar
  35. 35.
    Oguchi, M., J. Komura, H. Tagami, and S. Ofuji, Ultrastructural studies of spontaneously regressing plane warts. Langerhans cells show marked activation, Arch. Der matol Res. 271:55–61 (1981).Google Scholar
  36. 36.
    Jablonska, S., J. Dabrowski, and K. Jakubowicz, Epidermodysplasia verruciformis as a model in studies on the role of papova viruses in oncogenesis, Cancer Res. 32:583–589 (1972).PubMedGoogle Scholar
  37. 37.
    Glinski, W., S. Jablonska, A. Langner, S. Obalek, M. Haftek, and M. Proniewska, Cell-mediated immunity is epidermodysplasia verruciformis, Dermatologica 153:218–227 (1976).PubMedCrossRefGoogle Scholar
  38. 38.
    Glinski, A., S. Obalek, S. Jablonska, and G. Orth, T cell defect in patients with epidermodysplasia verruciformis due to human papillomavirus type 3 and 5, Dermatologica 162: 141–147 (1981).PubMedCrossRefGoogle Scholar
  39. 39.
    Prawer, S. E., F. Pass, J. C. Vance, E. J. Greenberg, E. J. Yunis, and A. S. Zelickson, Depressed immune function in epidermodysplasia verruciformis, Arch. Dermatol. 113:495–499 (1977).PubMedCrossRefGoogle Scholar
  40. 40.
    Obalek, S., W. Glinski, M. Haftek, G. Orth and S. Jablonska, Comparative studies on cell mediated immunity in patients with different warts, Dermatologica 161:75–83 (1980).CrossRefGoogle Scholar
  41. 41.
    Jablonska, S., Orth, G., Glinski, G., Obalek, S., Jarzabek-Chorzelska, M., Croissant, O., Favre, M., and Rzesa, G., Morphology and immunology of human warts and familial warts, in: Leukaemias, Lymphomas and Papillomas: Comparative Aspects P. A. Bachmann, (ed.), pp. 107–131. Taylor and Francis, London (1980).Google Scholar
  42. 42.
    Morison, W. L., Cell-mediated immune responses in patients with warts, Br. J. Dermatol. 93:553–556 (1975).PubMedCrossRefGoogle Scholar
  43. 43.
    Chretien, J. H., J. G. Essweins, and V. F. Garagusi, Decreased T cell levels in patients with warts, Arch. Dermatol. 114:213–215 (1978).PubMedCrossRefGoogle Scholar
  44. 44.
    Seski, J. C., E. R. Reinhalter, and J. Silva, Jr., Abnormalities of lymphocyte transformations in women with condylomata acuminata, Obstet. Gynecol. 51:188–192 (1977).Google Scholar
  45. 45.
    Sillman, F., A. Stanek, A. Sedlis, J. Rosenthal, K. W. Lanks, D. Buchhagen, A. Nicastri, and J. Boyce, The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women, Am. J. Obstet. Gynecol. 150:300–308 (1984).PubMedGoogle Scholar
  46. 46.
    Jablonska, S., S. Obalek, G. Orth, M. Haftek, and M. Jarzabek-Chorzelska, Regression of the lesions of epidermodysplasia verruciformis, Br. J. Dermatol. 107:109–116 (1982).PubMedCrossRefGoogle Scholar
  47. 47.
    Freed, D. L. J., and K. E. Eyres, Persistent warts protected from immune attack by a blocking factor, Br. J. Dermatol. 100:731–733 (1979).PubMedCrossRefGoogle Scholar
  48. 48.
    Gissmann, L., Papillomaviruses and their association with cancer in animals and in man, Cancer Surv. 3:161–181 (1984).Google Scholar
  49. 49.
    Gissmann, L., L. Wolnik, H. Ikenberg, U. Koldovsky, H. G. Schnurch, and H. zur Hausen, Human papillomavirus type 6 and 11 DNA sequences in genital and laryngeal papillomas and in some genital cancers, Proc. Natl. Acad. Sci. USA 80:560–563 (1983).PubMedCrossRefGoogle Scholar
  50. 50.
    McCance, D. J., P. G. Walker, J. L. Dyson, D. V. Coleman, and A. Singer, Presence of human papillomavirus DNA sequences in cervical intraepithelial neoplasia, Br. Med. J. 287:784–788 (1983).CrossRefGoogle Scholar
  51. 51.
    Rowe, W. P., J. W. Hartley, L. W. Law, and R. J. Huebner, Studies of mouse polyoma virus infection. III. Distribution of antibodies in mouse colonies, J. Exp. Med. 109:449– 462 (1959).PubMedCrossRefGoogle Scholar
  52. 52.
    Law, L. W., C. J. Dawe, W. P. Rowe, and J. W. Hartley, Antibody status of mice and response of their litters to paroid tumor virus (polyomavirus), Nature (Lond.) 184:1420– 1421 (1959).CrossRefGoogle Scholar
  53. 53.
    Rowe, W. P., J. W. Hartley, and R.J. Huebner, The ecology of a mouse tumor virus, in: Perspectives in Virology ,Vol.II (M. Pollard, (ed.), pp. 117–194, Rutgers University Press, New Brunswick, New Jersey (1961).Google Scholar
  54. 54.
    Rowe, W. P., J. W. Hartley, J. D. Estes, and R.J. Huebner, Growth curves of polyoma in mice and hamsters, in: Symposium on Phenomena of the Tumor Viruses ,National Cancer Institute Monograph No. 4, pp. 187–209 (1960).Google Scholar
  55. 55.
    McCance, D. J., and C. A. Mims, Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy, Infect. Immun. 25: 998–1002 (1979).PubMedGoogle Scholar
  56. 56.
    McCance, D. J., Persistence of animal and human papovaviruses in renal and nervous tissues, in: Polyomaviruses and Human Neurological Diseases ,J. L. Sever and D. L. Madden, (eds), pp. 343–357, Liss, New York (1983).Google Scholar
  57. 57.
    McCance, D. J., Growth and persistence of polyoma early region deletion mutants in mice,/. Virol 39:958–962 (1981).PubMedGoogle Scholar
  58. 58.
    Allison, A.C., Immune responses to polyoma virus-induced tumors, in: Viral Oncology (G. Klein, (ed.), pp. 481–487, Raven, New York (1980).Google Scholar
  59. 59.
    McCance, D. J., A. Sebesteny, B. E. Griffin, F. Balkwill, R. Tilly, and N. A. Gregson, A paralytic disease in nude mice associated with polyomavirus infection, J. Gen. Virol. 64:57–67 (1983).PubMedCrossRefGoogle Scholar
  60. 60.
    McCance, D. J., and C. A. Mims, Transplacental transmission of polyomavirus in mice, Infect. Immun. 18:196–202 (1977).PubMedGoogle Scholar
  61. 61.
    Ashkenjai, A., and J. L. Melnick, Induced latent infection of monkeys with vacuolating SV40 papovavirus. Virus in kidneys and urine, Proc. Soc. Exp. Biol. Med. 111:367–372 (1962).Google Scholar
  62. 62.
    Shah, K. V., Neutralizing antibodies to Simian Virus 40 (SV40) in human sera from India, Proc. Soc. Exp. Biol. Med. 121:303–307 (1966).PubMedGoogle Scholar
  63. 63.
    Shah, K. V., Investigation of human malignant tumors in India for Simian Virus 40 etiology, J. Natl. Cancer Inst. 42:139–145 (1969).PubMedGoogle Scholar
  64. 64.
    Gerber, P., Pattern of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines, Proc. Soc. Exp. Biol. Med. 125:1284–1291 (1967).PubMedGoogle Scholar
  65. 65.
    Shah, K. V., H. L. Ozer, H. S. Pond, L. D. Palma, and G. P. Murphy, SV40 neutralizing antibodies in sera of US residents without history of polio immunization, Nature (Lond.) 231:448–450 (1971).CrossRefGoogle Scholar
  66. 66.
    Topp, W. C., D. B, Rifkin and U. J. Sleigh, SV40 mutants with an altered small-t protein are tumorigenic in newborn hamsters, Virology ,111:341–350 (1981).PubMedCrossRefGoogle Scholar
  67. 67.
    Aström, K. E., E. L. Mancall, and E. P. Richardson, Jr., Progressive multifocal leukoen-cephalopathy, Brain 81:93–111 (1958).PubMedCrossRefGoogle Scholar
  68. 68.
    Gribble, D. H., C. C. Haden, R. V. Henrickson, and L. W. Schwartz, Spontaneous progressive multifocal leukoencephalopathy (PML) in macaques, Nature (Lond.) 254:602–604 (1975).CrossRefGoogle Scholar
  69. 69.
    Holmberg, C. A., D. H. Gribble, K. K. Takemoto, P. M. Howley, C. Espana, and B. I. Osburn, Isolation of Simian Virus 40 from rhesus monkeys (Macaca mulatto) with spon taneous progressive multifocal leukoencephalopathy, J. Infect. Dis. 136:593–596 (1977).PubMedCrossRefGoogle Scholar
  70. 70.
    Padgett, B. L., and D. L. Walker, New human papovaviruses, Prog. Med. Virol. 22:1–35 (1976).PubMedGoogle Scholar
  71. 71.
    Gardner, S. D., Prevalence in England of antibody to human polyomavirus (B.K.), Br. Med. J. 1:77–78 (1973).PubMedCrossRefGoogle Scholar
  72. 72.
    Shah, K. V., R. W. Daniel, and R. M. Warszawski, High prevalence of antibodies to BK virus, an SV-40 related papovavirus, in residents of Maryland, J. Infect. Dis. 128:784– 787 (1973).PubMedCrossRefGoogle Scholar
  73. 73.
    Portolani, M., A. Marzocchi, G. Barbanti-Brodano, and M. La Placa, Prevalence in Italy of antibodies to a new human papovavirus (BK Virus), J. Med. Microbiol. 7:543–546 (1974).PubMedCrossRefGoogle Scholar
  74. 74.
    Brown, P., T. Tsai, and D. C. Gajdusek, Seroepidemiology of human papovaviruses: Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world, Am. J. Epidemiol. 102:331–340 (1975).PubMedGoogle Scholar
  75. 75.
    Goudsmit, J., M. L. Baak, K. W. Slaterus, and J. van der Noordaa, Human papovavirus isolated from urine of a child with acute tonsillitis, Br. Med. J. 283:1363–1364 (1981).CrossRefGoogle Scholar
  76. 76.
    Goudsmit, J., P. Wertheim-van Dillen, A. van Strien, and J. van der Noordaa, The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils, J. Med. Virol. 10:91–99 (1982).PubMedCrossRefGoogle Scholar
  77. 77.
    Hashida, J., P. C. Gaffney, and E. J. Yunis, Acute haemorrhagic cystitis of childhood and papovavirus-like particles, J. Pediatr. 89:85–87 (1976).PubMedCrossRefGoogle Scholar
  78. 78.
    Mininberg, D. T., C. Watson, and M. Desquitado, Viral cystitis with transient secondary vesicoureteral reflux, J. Urol. 127:983–985 (1982).PubMedGoogle Scholar
  79. 79.
    Padgett, B. L., D. L. Walker, M. M. Desquitado, and D. V. Kim, BK virus and non-haemorrhagic cystitis in a child, Lancet 1:770 (1983).PubMedCrossRefGoogle Scholar
  80. 80.
    van der Noordaa, J., and P. Wertheim-van Dillen, Rise in antibodies to human papovavirus BK and clinical disease, Br. Med. J. 1:1471 (1977).PubMedCrossRefGoogle Scholar
  81. 81.
    Heritage, J., P. M. Chesters, and D. J. McCance, The persistence of papovavirus BK DNA sequences in normal human renal tissue, J. Med. Virol. 8:143–150 (1981).PubMedGoogle Scholar
  82. 82.
    Chesters, P. M., J. Heritage, and D. J. McCance, Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues, J. Infect. Dis. 147:676–684 (1983).PubMedCrossRefGoogle Scholar
  83. 83.
    Grinnell, B. W., B. L. Padgett, and D. L. Walker, Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoen-cephalopathy,/. Infect. Disc. 147:669–675 (1983).CrossRefGoogle Scholar
  84. 84.
    Drummond, J. E., K. V. Shah, and A. D. Donnenberg, Cell-mediated immune responses to BK virus in normal individuals, J. Med. Virol. 17:237–247 (1985).PubMedCrossRefGoogle Scholar
  85. 85.
    Lecatsas, G., B. D. Schoub, A. R. Rabson, and M. Joffe, Papovavirus in human lymphocyte cultures, Lancet 2:907–908 (1976).PubMedCrossRefGoogle Scholar
  86. 86.
    Lecatsas, G., E. Blignaut, and B. D. Schoub, Lymphocyte stimulation by urine-derived human polyoma virus (BK), Arch. Virol 55:165–167 (1977).PubMedCrossRefGoogle Scholar
  87. 87.
    Portolani, M., M. Piani, G. Gazzanelli, M. Borgatti, A. Bartoletti, M. P. Grossi, A. Corallini, and G. Barbanti-Brodano, Restricted replication of BK virus in human lymphocytes, Microbiologic 8:59–66 (1985).Google Scholar
  88. 88.
    Possati, L., C. Rubini, M. Portolani, G. Gazzanelli, M. Piani, and M. Borgatti, Receptors for the human papovavirus BK on human lymphocytes, Arch. Virol. 75:131–136 (1983).PubMedCrossRefGoogle Scholar
  89. 89.
    Coleman, D. V., Recent developments in the papovaviruses: the human polyomaviruses (BK virus and JC virus), in: Recent Advances in Clinical Virology (A. P. Waterson, (ed.), pp. 89–110, Churchill Livingstone, London (1980).Google Scholar
  90. 90.
    Coleman, D. V., A. M. Field, S. D. Gardner, K. A. Porter, and T. E. Starzl, Virus-induced obstruction of the ureteric and cystic duct in allograft recipients, Transplant. Proc. 5:95–98 (1973).PubMedGoogle Scholar
  91. 91.
    Coleman, D. V., E. F. D. Mackenzie, S. D. Gardner, J. M. Poulding, B. Amer, and W. J. I. Russell, Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients,/. Clin. Pathol ,31:338–347 (1978).PubMedCrossRefGoogle Scholar
  92. 92.
    Zu Rhein, G. M., Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy), Prog. Med. Virol. 11:185–247 (1969).PubMedGoogle Scholar
  93. 93.
    Willoughby, E., R. W. Price, B. L. Padgett, D. L. Walker, and B. Dupont, Progressive multifocal leukoencephalopathy (PML): In vitro cell-mediated immune responses to mitogens and JC virus, Neurology (NY) 30:256–262 (1980).Google Scholar
  94. 94.
    Borgatti, M., F. Costanzo, M. Portolani, C. Vullo, L. Osti, M. Masi, and G. Barbanti-Brodano, Evidence for reactivation of persistent infection during pregnancy and lack of congenital transmission of BK virus, a human papovavirus, Microbiologica 2:173–178 (1979).Google Scholar
  95. 95.
    Coleman, D. V., S. D. Gardner, C. Mulholland, V. Fridiksdottir, A. A. Porter, R. Lilford,and H. Valdimarsson, Human polyomavirus in pregnancy. A model for the study of defence mechanisms to virus reactivation, Clin. Exp. Immunol. 53:289–296 (1983).PubMedGoogle Scholar
  96. 96.
    Panem, S., N. G. Ordonez, A. I. Katz, B. H. Spargo, and W. H. Kirsten, Viral immune complexes in systemic lupus erythematosus, Lab. Invest. 39:413–420 (1978).PubMedGoogle Scholar
  97. 97.
    Donini, U., F. Poli, L. Rossi, F. Palanchetti, G. Altavilla, A. Corallini, P. Zucchelli, and G. Barbanti-Brodano, A search for BK virus immune complexes in human nephropathies: immunological cross-reaction between BK virus structural antigens and human immu noglobulins, Microbiologica 4:87–100 (1981).Google Scholar
  98. 98.
    Howley, P. M., Molecular biology of SV40 and the human polyomaviruses BK and JC, in: Viral Oncology (G. Klein, ed.), pp. 489–550, Raven, New York (1980).Google Scholar
  99. 99.
    Padgett, B., Human papovaviruses, in: Molecular Biology of Tumor Viruses ,Vol. 2: DNA Tumor Viruses ,J. Tooze (ed.), pp. 339–370, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1980).Google Scholar
  100. 100.
    London, W. T., S. A. Houff, D. L. Madden, D. A. Faccillo, M. Gravell, W. C. Wallen, A. E. Palmer, J. L. Sever, B. L. Padgett, D. L. Walker, and G. M. Zu Rhein, Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus), Science 210:1246–1249 (1978).CrossRefGoogle Scholar
  101. 101.
    Uchida, S., S. Watanabe, T. Aizawa, K. Kato, A. Furuno, and T. Muto, Induction of papillary ependymomas and insulinomas in the Syrian golden hamster by BK virus, a human papovavirus, Gann 67:857–865 (1976).PubMedGoogle Scholar
  102. 102.
    Costa, T., C. Yee, T. S. Trakla, and A. S. Rabson, Hamster ependymomas produced by intracerebral inoculation of human papovavirus (MMV), J. Natl. Cancer Inst. 56:863–864 (1976).PubMedGoogle Scholar
  103. 103.
    Corallini, A., G. Barbanti-Brodano, W. Bortoloni, I. Nenci, E. Cassai, M. Tampieri, M. Portolani, and M. Borgatti, High incidence of ependymomas induced by BK virus, a human papovavirus, J. Natl. Cancer Inst. 59:1561–1563 (1977).PubMedGoogle Scholar
  104. 104.
    Corallini A., G. Altavilla, M. G. Cecchetti, G. Fabris, M. P. Grossi, P. G. Balboni, G. Lanza, and G. Barbanti-Brodano, Ependymomas, malignant tumors of pancreatic islets and osteosarcomas induced in hamsters by BK virus, a human papovavirus, J. Natl. Cancer Inst. 61:875–883 (1978).PubMedGoogle Scholar
  105. 105.
    Uchida, S., S. Watanabe, T. Aizawa, A. Furuno and T. Muto, Polyoncogenicity and insulinoma-inducing ability of BK virus, a human papovavirus, in syrian golden hamsters,/. Natl. Cancer Inst. 63:119–126 (1979).PubMedGoogle Scholar
  106. 106.
    Corallini, A., G. Altavilla, L. Carrà, M. P. Grossi, G. Federspil, A. Caputo, M. Negrini, and G. Barbanti-Brodano, Oncogenicity of BK virus for immunosuppressed hamsters, Arch. Virol 73:243–253 (1982).PubMedCrossRefGoogle Scholar
  107. 107.
    zur Hausen, H., and L. Gissmann, Lymphotropic papovavirus isolated from African green monkey and human cells, Med. Microbiol. Immunol. 167:137–153 (1979).PubMedCrossRefGoogle Scholar
  108. 108.
    Pawlita, M., A. Clad, and H. zur Hausen, Complete DNA sequence of lymphotropic papovavirus: Prototype of a new species of the polyomavirus genus, Virology 143:196–211 (1985).PubMedCrossRefGoogle Scholar
  109. 109.
    Takemoto, K. K., and T. Kanda, Lymphotropic papovavirus transformation of hamster embryo cells,/. Virol 50:100–105 (1984).PubMedGoogle Scholar
  110. 110.
    Mosthaf, L., M. Pawlita, and P. Gruss, A viral enhancer element specifically active in human haematopoietic cells, Nature (Lond.) 315:597–600 (1985).CrossRefGoogle Scholar
  111. 111.
    Kanda, T., and K. K. Takemoto, Monkey B-lymphotropic papovavirus mutant capable of replicating in T-lymphoblastoid cells, J. Virol 55:96–100 (1985).PubMedGoogle Scholar
  112. 112.
    Brade, L., N. Müller-Lantzsch, and H. zur Hausen, B-lymphotropic papovavirus and possibility of infection in humans, J. Med. Virol. 6:301–308 (1980).CrossRefGoogle Scholar
  113. 113.
    zur Hausen, H., Gissmann, L. Mincheva, A., and Böcher, J. F. Characterization of a lymphotropic papovavirus, in Viruses in Naturally Occurring Cancers (M. Essex, G. Todaro, and H. zur Hausen, (eds). pp. 365–372, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York (1980).Google Scholar
  114. 114.
    Bates, M. P., S. R. Jennings, Y. Tanaka, M. J. Tevethia, and S. S. Tevethia, Recognition of simian virus 40 T antigen synthesized during viral lytic cycle in monkey kidney cells expressing mouse H-2Kb-and H-2Db-transfected genes by SV40-specific cytotoxic T lymphocytes leads to the abrogation of virus lytic cycle, Virology 162:197–205 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Giuseppe Barbanti-Brodano
    • 1
  1. 1.Institute of Microbiology, School of MedicineUniversity of FerraraFerraraItaly

Personalised recommendations